Jan-Frens van Giessel

Jan-Frens van Giessel is an experienced professional currently serving as a Board Member at Honic and active as a Partner at Holland Capital since March 2018. Van Giessel holds multiple board positions including those at Sirius Medical, HealthConnected (NL), and Kriya Materials B.V., among others. Additionally, van Giessel is a member of the Investment Committees for First Fund and RedMedTech Discovery Fund. Previous roles include Board Member at Xilloc, Shareholder Representative at Ventinova Medical, and Board Member at NightWatch Epilepsy Detection. Jan-Frens van Giessel earned a Master of Science degree in Science and Innovation Management from Utrecht University and completed VWO at De Heemgaard in Apeldoorn.